These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28157224)
1. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Jeng BH; Holsclaw DS Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568 [TBL] [Abstract][Full Text] [Related]
3. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis. Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547 [TBL] [Abstract][Full Text] [Related]
5. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949 [TBL] [Abstract][Full Text] [Related]
6. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086 [TBL] [Abstract][Full Text] [Related]
7. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis. Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. Ghanem RC; Vargas JF; Ghanem VC Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis]. Maychuk DY; Vasil'eva OA; Russu LI; Mezentseva MV Vestn Oftalmol; 2015; 131(4):49-55. PubMed ID: 26489119 [TBL] [Abstract][Full Text] [Related]
10. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis. Arici C; Mergen B Br J Ophthalmol; 2021 May; 105(5):614-618. PubMed ID: 32563992 [TBL] [Abstract][Full Text] [Related]
11. [Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report]. Reinhard T; Sundmacher R Klin Monbl Augenheilkd; 1997 Mar; 210(3):165-8. PubMed ID: 9206749 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates. Zghal I; Fekih O; Zgolli HM; Chargui S; Malek I; Nacef L Tunis Med; 2019 May; 97(5):639-643. PubMed ID: 31729734 [TBL] [Abstract][Full Text] [Related]
13. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study. Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059 [TBL] [Abstract][Full Text] [Related]